Rădulescu Daniela, Ferechide Dumitru
"Carol Davila" University of Medicine and Pharmacy, Nephrology Clinic, "Sf Ioan" Clinical Emergency Hospital, Bucharest, Romania.
J Med Life. 2009 Apr-Jun;2(2):199-206.
In the last decade, many researches have reached to the conclusion that preservation of residual renal function (RRF) is important after initiating dialysis, as well as in the predialysis period. RRF has been proven to contribue to the quality of life of dialysis patients. Longer preservation of RRF provides a better small and middle molecule removal, improved volemic status and arterial pressure control, diminished risk of vascular and valvular calcification due to better phosphate removal. Deterioration of RRF results in worsening of anemia, inflammation and malnutrition. It is now proven a direct relationship between RRF value and survival in dialysis patient. Several therapeutical intervention have been proven to ameliorate the decline of RRF in dialysis patients. Some of them are identical with those before initiating dialysis: ACE-inhibitors and/or angiotensin-receptor blockers, limiting the use of nephrotoxic drugs, avoiding contrast media procedures, adequate control of blood pressure. Others are specific for dialysis period: adequate dialysis dose, avoiding excessive ultrafiltration, preventing arterial hypotension during dialysis sessions, using biocompatible dialysis membranes, ultrapure water for dialysis, dietary interventions.
在过去十年中,许多研究得出结论,残余肾功能(RRF)的保留在开始透析后以及透析前期都很重要。RRF已被证明有助于透析患者的生活质量。RRF保留时间越长,小分子和中分子清除效果越好,血容量状态和动脉血压控制得到改善,由于更好地清除磷酸盐,血管和瓣膜钙化风险降低。RRF恶化会导致贫血、炎症和营养不良加重。现已证实RRF值与透析患者的生存率之间存在直接关系。已证明几种治疗干预措施可改善透析患者RRF的下降。其中一些与开始透析前的措施相同:使用血管紧张素转换酶抑制剂和/或血管紧张素受体阻滞剂、限制使用肾毒性药物、避免造影剂检查、充分控制血压。其他措施则是透析期特有的:足够的透析剂量、避免过度超滤、防止透析过程中动脉低血压、使用生物相容性透析膜、使用超纯水进行透析、饮食干预。